#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Keratosis follicular Lip and/or oral cavity cancer Pulmonary fibrosis Hypereosinophilic syndrome Cataract Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Hypocalcaemia B-cell lymphoma refractory HER2 mutant non-small cell lung cancer Anal squamous cell carcinoma Von Willebrand's disease Systemic sclerosis pulmonary Sickle cell disease Metastatic gastric cancer Chondrosarcoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Haemophilia A without inhibitors Epidermolysis bullosa – Treatment Noonan syndrome – Diagnostics Kearns-Sayre syndrome – Life with Disease Osteosarcoma – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Basal cell naevus syndrome – Basic Information Mantle cell lymphoma stage II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ranitidine Resiquimod Sulfate ATTR-01 Loperamide Hydrochloride Cabotegravir Progesterone Ethanol, Anhydrous Demeclocycline Hydrochloride Rilvegostomig BENZYDAMINE HYDROCHLORIDE Hct116-B Hu5F9‐G4 Alemtuzumab SURVODUTIDE AMG 732 Cendakimab Valine Cx-039776 Valaciclovir Rineterkib More therapies…

    Learn about Your Condition

    Cervix carcinoma stage I Hypochromic anaemia Gaucher's disease type I Tympanic membrane perforation Non-obstructive cardiomyopathy Peritoneal abscess Biliary tract operation Ehlers-Danlos syndrome Gingival bleeding Hypertrophic cardiomyopathy Lymphocytic lymphoma Venous thrombosis Acarodermatitis Thrombocytosis Cardiac sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Caffeine
    France

  • Study on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Spiramycin
    • Amoxicillin Sodium
    • Cefepime Hydrochloride
    France

  • Study of Avelumab with Chemotherapy for Patients with Resectable Stomach or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    • Gastric cancer
    Investigated Drugs:
    • Avelumab
    • Calcium Folinate
    • Docetaxel
    Spain

  • Study on Obinutuzumab vs. Rituximab for Children with Steroid-Dependent and Frequent Relapsing Nephrotic Syndrome

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Obinutuzumab
    • Rituximab
    France

  • Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Austria France Germany Italy Spain

  • Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Treg02
    • Valganciclovir Hydrochloride
    • Methylprednisolone Sodium Succinate
    Germany
Previous Page
1 … 399 400 401 402 403 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!